Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Standard Operating Procedure for Bioburden Testing

Posted on By

Standard Operating Procedure for Bioburden Testing

Purpose:

The purpose of this Standard Operating Procedure (SOP) is to provide guidelines and procedures for determining the microbial bioburden in raw materials or finished products within the pharmaceutical manufacturing facility. This helps ensure compliance with regulatory requirements and product safety standards.

Scope

This SOP applies to all personnel involved in bioburden testing procedures within the pharmaceutical manufacturing facility.

Responsibilities

  • Quality Control (QC) Department: Responsible for overseeing the implementation and compliance of this SOP.
  • Microbiologist: Responsible for performing bioburden testing according to the procedures outlined in this SOP.
  • Production Personnel: Responsible for providing samples for bioburden testing and ensuring proper documentation.
See also  SOP for Microbial Contamination ControlĀ 

Procedure

  1. Sample Collection and Preparation:
    • Collect representative samples of raw materials or finished products to be tested.
    • Prepare samples according to specified methods and dilutions, if required.
  2. Inoculation and Incubation:
    • Inoculate suitable culture media with the prepared samples using aseptic techniques.
    • Incubate cultures under specified conditions to promote microbial growth.
    • Incubation periods may vary depending on the type of sample and regulatory requirements.
  3. Enumeration of Microorganisms:
    • Count microbial colonies using suitable enumeration techniques such as pour plate or membrane filtration.
    • Record colony counts and calculate the bioburden level per unit of sample.
  4. Identification of Microorganisms:
    • Perform biochemical tests or other identification methods to characterize microbial isolates, if required.
    • Record and interpret identification results as per
regulatory guidelines.
  • Documentation and Reporting:
    • Document all test results, observations, and calculations accurately and legibly.
    • Report bioburden testing results to the appropriate personnel and maintain records as per regulatory requirements.
  • Abbreviations

    • SOP: Standard Operating Procedure
    • QC: Quality Control

    Documents

    • Bioburden Testing Records
    • Incubation Log
    • Identification Results

    Reference

    United States Pharmacopoeia (USP) General Chapter Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests

    SOP Version

    Version 1.0

    See also  SOP for Microscopic Examination
    Microbiology Testing Tags:Bioburden testing, Change control management, Data review processes, Decontamination techniques, Disinfection procedures, Endotoxin testing, Environmental data trending, Environmental monitoring, Equipment Calibration, Excipient control, GMP compliance, Incident investigation, Incubation conditions, Laboratory safety guidelines, Media fill testing, Media preparation, Method Validation, Microbial contamination control, Microbial strain verification, Quality control measures, Raw Material Testing, Reagent preparation, Sampling protocols, Sterility testing, Water quality testing

    Post navigation

    Previous Post: Microbiology Testing: SOP for Endotoxin Testing
    Next Post: Microbiology Testing: SOP for Cross-Contamination Prevention

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version